NCT05115032

Brief Summary

People that have difficulty with balance have a higher risk of falling and reduced quality of life. Some individuals can learn to compensate using their vision, their sense of where their limbs are in space, and balance organs that are still intact. Rehabilitation exercises, which typically involve shaking and nodding of the head, are often prescribed for dizzy patients but are not effective for everyone. Our study aims to determine if specific exercises performed on footplate sensors with visual feedback is superior to traditional rehabilitation exercises done at home for improving balance and quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
37

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2021

Completed
12 days until next milestone

First Posted

Study publicly available on registry

November 10, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

January 17, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 19, 2023

Completed
Last Updated

April 10, 2025

Status Verified

May 1, 2024

Enrollment Period

11 months

First QC Date

October 29, 2021

Last Update Submit

April 7, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • SOT composite score

    Change in composite score of sensory organization test (Scores from 0-100; higher scores indicate better function)

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • Dizziness Handicap Inventory

    Change in Dizziness Handicap Inventory (DHI); 16-30 Points (mild handicap), 32-52 Points (moderate handicap), 54+ Points (severe handicap)

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

Secondary Outcomes (7)

  • ABC Score

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • FES-I score

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • SOT condition scores

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • LOS directional control

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • LOS excursion

    Through study completion, 12 rehabilitation sessions, an average of 7 weeks

  • +2 more secondary outcomes

Study Arms (2)

Vestibular retraining with dynamic posturography

EXPERIMENTAL

12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback

Device: Vestibular retraining with dynamic posturography

At-home rehabilitation exercises

ACTIVE COMPARATOR

Daily rehabilitation exercises involving nodding and shaking of the head

Behavioral: At-home rehabilitation exercises

Interventions

12 sessions, twice per week, of rehabilitation exercises last about 20 minutes, using CDP and interactive visual feedback

Vestibular retraining with dynamic posturography

6 weeks of daily rehabilitation exercises involving nodding and shaking of the head

At-home rehabilitation exercises

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Dizziness handicap inventory score at time of enrolment over 30
  • Unilateral vestibular weakness confirmed one or more of:
  • Videonystagmography showing unilateral weakness to bithermal testing of greater than 25%
  • VEMP: IAD asymmetry of greater than 40% for both cVEMP and oVEMP
  • VEMP: absence of both ocular and cervical vemp responses in one ear in the context of normal and replicable other ear
  • Or unilateral vestibular weakness idiopathic, not yet diagnosed (NYD)
  • Persistent imbalance following diagnosis of resolved benign paroxysmal positional vertigo (BPPV)
  • Symptomatic
  • Long-standing/persistent symptoms greater than six months

You may not qualify if:

  • Orthopedic deficit (eg. lower body joint dysfunction or lower joint replacement)
  • Neurological deficit or proprioception deficit
  • Diabetes
  • Poor vision or blindness
  • Fluctuating vestibular symptoms, or condition known to fluctuate eg. Menière's disease, perilymphatic fistula (PLF) or superior canal dehiscence (SDCS)
  • Active benign paroxysmal positional vertigo (BPPV)
  • Undergoing treatment which may affect balance or ability to stand
  • Cognitive impairment that prevents understanding and responding to instructions required to complete the study
  • Inability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. EA David MD FRCSC

North Vancouver, British Columbia, V7M 2H5, Canada

Location

Related Publications (1)

  • David EA, Shahnaz N, Wiseman I, David Y, Cochrane CL. Vestibular Rehabilitation Using Dynamic Posturography: Functional Stability and Fall Risk Outcomes From a Randomized Trial. Otolaryngol Head Neck Surg. 2025 Sep;173(3):713-723. doi: 10.1002/ohn.1302. Epub 2025 Jul 7.

MeSH Terms

Conditions

DizzinessLabyrinth Diseases

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsEar DiseasesOtorhinolaryngologic Diseases

Study Officials

  • Eytan A David, MD

    University of British Columbia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: Randomized controlled interventional trial; single crossover; single-centre, open label
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
MD, FRCSC, Clinical Instructor, Dept. of Surgery

Study Record Dates

First Submitted

October 29, 2021

First Posted

November 10, 2021

Study Start

January 17, 2022

Primary Completion

December 15, 2022

Study Completion

April 19, 2023

Last Updated

April 10, 2025

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations